Pro Medicus 获得美国公司合同股价攀升近4%

澳华财经在线：首页 > 市场观察 > 异动个股

2021-10-01 09:50:35 来源：《澳华财经在线》 编辑：Tony 文章类型：编译

ACB News《澳华财经在线》10月1日讯医学成像技术公司Pro Medicus(ASX:PME)周五发布公告称，已与美国医疗保健提供商 Novant Health 签署了一份为期7年、价值 4000 万澳元的合同。

首席执行官Sam Hupert博士表示，该合同是公司在不到18个月的时间里在北美签订的第七份主要合同，也是迄今为止最大的一份合同，这支撑了公司在北美市场上持续建立的强劲势头。

3Pro Medicus 获得美国2.jpg

( 图片来源：《澳华财经在线》)

受该公告影响，Pro Medicus 股价周五早盘上涨。至发稿时为止，该股成交价为54.61澳元，上扬2.04澳元，涨幅3.88%。该股近一年的投资回报率为106.39%。

参考资料来源：澳洲金融评论，澳交所

【小编贴士：】手机端阅读时，点击文章页面左上Logo即可返回首页阅读。祝读者朋友天天健康、开心！工作投资顺利。

免责声明：本文为财经观察评论，不构成任何投资建议，交易操作或投资决定请询问专业人士。

( 郑重声明：ACB News《澳华财经在线》对标注为原创的文章保留全部著作权限，任何形式转载请标注出处。)

Tags: PME 医学成像技术签署美国 Novant Health 合同股价 Pro Medicus

相关阅读

: Avenira Limited (ASX: AEV) Appoints John He as Executive Chairman and CEO to Accelerate Wonarah Phosphate Project Development and Strengthen Strategic Partnerships

ACB News, Sydney – 20 October 2025: Avenira Limited (ASX: AEV), an ASX-listed battery cathode and fertiliser project developer, announced the appointment of Mr. John He as Executive Chairman and Chief Executive Officer, effective from 17 October 2025. Ms. Stephanie Yuan, former Chair and CEO, will remain on the Board as a Non-Executive Director.

: Future Minerals Forum 2026 to Convene Global Leaders in Riyadh, Focusing on Energy Transition and Sustainable Development

ACB News, Sydney 29 Sep 2025 — The Future Minerals Forum (FMF) 2026 will take place from 13–15 January 2026 at the King Abdulaziz International Conference Center in Riyadh, Saudi Arabia. Organized under the auspices of the Saudi Ministry of Industry and Mineral Resources, the forum is positioned as a premier global platform dedicated to shaping the future of minerals and metals amid the accelerating global energy transition.

: A new platform suggests a new dimension of China's development

At a time when the global economic structure is undergoing profound adjustments and technological changes are accelerating, China is breaking through with a higher level of institutional opening.

: 2月份澳交所生物科技板块表现惨淡分析师称抛盘之后呈现绝佳机遇

券商Wilsons的分析师Shane Storey博士表示，2月份财报季澳交所生物科技板块经历大范围暴跌，但其中也创造出新的买入机会。

: 2月份澳交所生物科技板块表现惨淡分析师称抛盘之后呈现机遇

券商Wilsons的分析师Shane Storey博士表示，2月份财报季澳交所生物科技板块经历大范围暴跌，但其中也创造出新的买入机会。

: 【异动股】Medical Developments International (ASX:MVP)飙涨20%：本财年末预计实现正向现金流

Medical Developments International Ltd (ASX股票代码:MVP)股价异动，周一MVP澳交所股价飙涨19.55%，报0.795澳元，成交量144万股。今年以来该股上涨96.30%。

: 【异动股】Resource Development Group(ASX:RDG) 硫酸锰电池材料试产成功股价飙升

矿业工程与电池材料公司Resource Development Group Ltd (ASX股票代码:RDG) 股价异动，周三RDG澳交所股价飙涨20.00%，报0.024澳元，成交量49万股。过去一年该股下跌46.67%。

: AI applications are a key force to promote economic development

On November 12th, at the Baidu World 2024, Robin Li, the co-founder of Baidu, delivered a keynote speech titled "Application are here". In his speech, Robin said that “Baidu isn’t aiming to launch a ‘super app’; instead, we aim to help more people and businesses create millions of ‘super useful’ apps”, reflecting the key to AI application lies in its practicality.

免责声明：本网站信息仅供一般参考，不构成投资或财务建议。虽力求准确与完整，但不保证信息的准确性、完整性或时效性。投资有风险，决策前请咨询专业独立顾问。使用本网站即视为接受本免责声明。